Skip to content

Hymecromone

ALIMENTARY TRACT AND METABOLISM

Also known as: bilcolic, bilicante, cantabilin, cholestil, cholspasmin, imecromone, mendiaxon

ATC A05AX02

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Hymecromone is a drug catalogued in DrugCentral. DrugCentral lists 7 molecular targets, including CA9, HSD17B3 and CA12.

  • Molecular targets: CA9, HSD17B3, CA12 and MCL1 (7 listed in DrugCentral).
  • ATC code: A05AX02 (Other drugs for bile therapy).
  • Molecular formula: C10H8O3; molecular weight 176.17 g/mol.

Mechanism & targets

Molecular targets (7)

TargetGeneActionActivity
Carbonic anhydrase 9CA9unknownKi 6.25
Testosterone 17-beta-dehydrogenase 3HSD17B3unknownIC50 6.00
Carbonic anhydrase 12CA12unknownKi 5.09
Induced myeloid leukemia cell differentiation protein Mcl-1MCL1unknownKi 4.66
Aldose reductaseAKR1B1unknownIC50 4.61
Aldose reductaseAkr1b1unknownIC50 4.21
Amine oxidase [flavin-containing] BMAOBunknownIC50 4.09

ATC classification

ATC codeTherapeutic hierarchy
A05AX02ALIMENTARY TRACT AND METABOLISM › BILE AND LIVER THERAPY › BILE THERAPY › Other drugs for bile therapy

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Hymecromone is on its molecule page.

Molecular formulaC10H8O3
Molecular weight176.17 g/mol
CAS number90-33-5
InChIKeyHSHNITRMYYLLCV-UHFFFAOYSA-N
PubChem CID5280567
CC1=CC(=O)OC2=C1C=CC(O)=C2

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Hymecromone work?

Its molecular targets in DrugCentral include CA9, HSD17B3, CA12 and MCL1.

What is the chemical formula of Hymecromone?

Hymecromone has the molecular formula C10H8O3 and a molecular weight of 176.17 g/mol.

Browse: all drugs starting with H · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets7
Indications0
FormulaC10H8O3
DrugCentral ID1401
Interactive profile